Data di Pubblicazione:
2021
Citazione:
Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications / G. Vitale, A. Cozzolino, P. Malandrino, R. Minotta, G. Puliani, D. Saronni, A. Faggiano, A. Colao. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 12(2021 Apr 14), pp. 665631.1-665631.9. [10.3389/fendo.2021.665631]
Abstract:
Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors originating from neuroendocrine cells dispersed in different organs. Receptor tyrosine kinases are a subclass of tyrosine kinases with a relevant role in several cellular processes including proliferation, differentiation, motility and metabolism. Dysregulation of these receptors is involved in neoplastic development and progression for several tumors, including NENs. In this review, we provide an overview concerning the role of the fibroblast growth factor (FGF)/fibroblast growth factor receptor (FGFR) system in the development and progression of NENs, the occurrence of fibrotic complications and the onset of drug-resistance. Although no specific FGFR kinase inhibitors have been evaluated in NENs, several clinical trials on multitarget tyrosine kinase inhibitors, acting also on FGF system, showed promising anti-tumor activity with an acceptable and manageable safety profile in patients with advanced NENs. Future studies will need to confirm these issues, particularly with the development of new tyrosine kinase inhibitors highly selective for FGFR.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
FGF (fibroblast growth factor); FGFR (fibroblast growth factor receptor); neuroendocrine neoplasms; VEGF - vascular endothelial growth factor; VEGFR - vascular endothelial growth factor receptor
Elenco autori:
G. Vitale, A. Cozzolino, P. Malandrino, R. Minotta, G. Puliani, D. Saronni, A. Faggiano, A. Colao
Link alla scheda completa:
Link al Full Text: